T1	p 81 134	postmenopausal breast cancer survivors with bone loss
T2	p 381 423	223 postmenopausal breast cancer survivors
T3	p 584 645	postmenopausal breast cancer survivors ( BCS ) with bone loss
T4	p 1111 1137	Postmenopausal BCS ( 223 )
T5	i 20 35	weight training
T6	i 227 252	weight training exercises
T7	i 666 677	risedronate
T8	i 680 687	calcium
T9	i 694 703	vitamin D
T10	i 896 937	strength/weight training ( ST ) exercises
T11	i 1164 1188	exercise plus medication
T12	i 1192 1202	medication
T13	i 1263 1270	calcium
T14	i 1285 1294	vitamin D
T15	i 1314 1325	risedronate
T16	i 1343 1351	exercise
T17	i 1375 1387	ST exercises
T18	i 1444 1455	medications
T19	i 1464 1474	exercising
T20	i 1656 1665	exercised
T21	i 2002 2010	exercise
T22	i 2165 2199	Strength/weight training exercises
T23	o 39 59	bone mineral density
T24	o 64 77	bone turnover
T25	o 349 377	bone mineral density ( BMD )
T26	o 498 501	BMD
T27	o 531 534	BMD
T28	o 718 746	bone mineral density ( BMD )
T29	o 840 853	bone turnover
T30	o 963 966	BMD
T31	o 992 1005	bone turnover
T32	o 1097 1100	BMD
T33	o 1507 1510	BMD
T34	o 1591 1601	Alkphase B
T35	o 1617 1626	serum NTx
T36	o 1694 1697	BMD
T37	o 1831 1841	Alkphase B
T38	o 1857 1866	Serum NTx
T39	o 1902 1923	BMD and bone turnover
T40	o 2036 2039	BMD
T41	o 2220 2223	BMD